The anti‐Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole
Authors:
- 1 September 1995
- Vol. 38 (9-10) , 389-393
Abstract
Summary. Bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole were tested for their activity against 23 isolates of Malassezia furfur by agar dilution in vitro. Topical formulations of the same agents were evaluated for efficacy against M. furfur skin infections in guinea pigs in vivo. The most potent inhibitor in vitro was ketoconazole (geometric mean minimum inhibitory concentration 0.51 μg ml‐1), followed by bifonazole (8.1 μg ml‐1), then miconazole (14 μg ml‐1), clotrimazole (15 μg ml‐1) and flutrimazole (16 μg ml‐1), with sertaconazole the least active (52 μg ml‐1). In animal experiments involving three consecutive days of topical treatments, bifonazole 1% cream, clotrimazole 1% cream, flutrimazole 1% and 2% creams, ketoconazole 2% cream and shampoo and miconazole 2% cream all reduced M. furfur dermatitis lesion severity below that of untreated control animals; however, sertaconazole 2% gel and cream showed no reduction in lesion severity below control. The results confirm that ketoconazole is a more potent inhibitor of M. furfur in vitro than other topical antifungal agents of its class and suggest that sertaconazole is the least effective of such agents among those tested.Zusammenfassung. Bifonazol, Clotrimazol, Flutrimazol, Ketoconazol, Miconazol und Sertaconazol wurden in vitro mittels Agardilution auf ihre Aktivität gegen 23 Isolate von Malassezia furfur getestet. Topische Formulierungen der gleichen Imidazole wurden in vivo auf ihre Wirksamkeit gegen M. furfur‐Hautinfektionen in Meerschweinchen untersucht. In vitro war der potenteste Inhibitor Ketoconazol (geometrisches Mittel MIC = 0.51 μg ml‐1), gefolgt von Bifonazol 8.1 μg ml‐1). Miconazol (14 μg ml‐1), Clotrimazol (15 μg ml‐1), Flutrimazol (16 μg ml‐1) und dem am wenigsten aktiven Sertaconazol (52 μg ml‐1). In Tierexperimenten, die drei aufeinanderfolgende Tage topische Behandlung umfaßten, reduzierten Bifonazol 1% Creme, Clotrimazol 1% Creme, Flutrimazol 1% und 2% Cremes, Ketoconazol 2% Creme und Shampoo sowie Miconazol 2% Creme alle den Schweregrad der M. furfur Hautläsionen unter den von unbehandelten Kontrolltieren: Sertaconazol 2% Gel und Creme zeigte jedoch keine Verringerung des Schweregrades der Läsionen unter die der Kontrolle. Die Ergebnisse bestätigen, daß Ketoconazol in vitro ein potenterer Inhibitor von M. furfur als andere topische antifungale Wirk‐stoffe seiner Klasse ist und sprechen dafür. daß Sertaconazol unter den getesteten Imidazolen am wenigsten wirksam ist.Keywords
This publication has 9 references indexed in Scilit:
- Der Effekt anti-seborrhoischer Substanzen gegen ber Pityrosporum ovale in vitroDie Dermatologie, 1994
- A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruffJournal of the American Academy of Dermatology, 1993
- A double‐blind trial of 1% ketoconazole shampoo versus placebo in the treatment of dandruffMycoses, 1992
- AN OVERVIEW OF EXPERIENCE WITH KETOCONAZOLE SHAMPOOInternational Journal Of Clinical Practice, 1991
- The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigsJournal of the American Academy of Dermatology, 1990
- Treatment of seborrhoeic dermatitis of the scalp with ketoconazole shampoo. A double-blind study.Acta Dermato-Venereologica, 1990
- Treatment of Dandruff With a 2% Ketoconazole Scalp Gel.International Journal of Dermatology, 1986
- A Comparison of Miconazole Nitrate and Selenium Disulfide as Anti‐dandruff AgentsInternational Journal of Dermatology, 1983
- Treatment of pityriasis capitis (dandruff) with econazole nitrateActa Dermato-Venereologica, 1977